Medivolve Announces CAN $1.2 Million Convertible Note Financing
December 23, 2022 19:00 ET
|
Medivolve Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 23, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV;...
Medivolve to Implement Share Consolidation
December 07, 2022 08:00 ET
|
Medivolve Inc.
TORONTO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: MEDVF; FRA: 4NC) will consolidate its common shares on the basis of one new common share for...
Medivolve Pivoting Towards Expansion of Service Offerings and Other Updates
November 14, 2022 18:41 ET
|
Medivolve Inc.
TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company“) (NEO: MEDV) (OTC: COPRF) (FRA: 4NC), a healthcare technology and services company, has began its transition...
Medivolve Announces Launch of Investor Awareness Campaign and Refiling of Q2 2022 Financial Statements
August 24, 2022 21:30 ET
|
Medivolve Inc.
TORONTO, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: COPRF; FRA: 4NC) is pleased to announce the launch of an investor marketing campaign to...
Medivolve Announces Q2 2022 Financial Results
August 15, 2022 21:00 ET
|
Medivolve Inc.
TORONTO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: COPRF; FRA: 4NC), a healthcare technology company that seeks to improve the US healthcare...
Medivolve Provides Update on its Mobile Clinic Network
July 26, 2022 06:30 ET
|
Medivolve Inc.
TORONTO, July 26, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare technology and services company, is pleased to provide an update...
Medivolve Announces Results of Annual and Special Shareholder Meeting
June 16, 2022 18:00 ET
|
Medivolve Inc.
TORONTO, June 16, 2022 (GLOBE NEWSWIRE) -- Medivolve, Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: COPRF; FRA:4NC), reports, in accordance with the policies of the NEO Exchange, that the...
Medivolve Announces Q1 2022 Financial Results
May 16, 2022 19:00 ET
|
Medivolve Inc.
Cash on hand was $8,327,812 as at March 31, 2022, up 7,309% compared to $112,397 as at December 31, 2021.Cash provided by operating activities was $8,211,415 in the three months ending March 31, 2022,...
Medivolve Announces Launch of Normal Course Issuer Bid
May 03, 2022 17:00 ET
|
Medivolve Inc.
TORONTO, May 03, 2022 (GLOBE NEWSWIRE) -- Medivolve, Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: COPRF; FRA: 4NC) is pleased to announce its intention to commence a Normal Course Issuer Bid...
Medivolve Welcomes Vincent Chen as VP of Corporate Development
April 06, 2022 17:00 ET
|
Medivolve Inc.
TORONTO, April 06, 2022 (GLOBE NEWSWIRE) -- Medivolve, Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: COPRF; FRA:4NC) announced today that Vincent Chen, CPA, has joined the Company as VP of...